PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
12464674-3	2002	We hypothesized that the transfer of long-chain fatty acids (LCFAs) into the mitochondria via carnitine palmitoyltransferase-1 (CPT-1) is inhibited by increased malonyl coenzyme A (malonyl-CoA) (a known potent inhibitor of CPT-1) in human muscle during hyperglycemia with hyperinsulinemia.	lcfas	61-66	carnitine palmitoyltransferase 1A	Homo sapiens	94-126
17130495-1	2006	The secretagogue, the incretin-like, and the suppressive activities of long-chain fatty acids (LCFAs) in modulating insulin secretion in vivo and in cultured islets were simulated here by beta,beta"-tetramethyl-hexadecanedioic acid (M16) and alpha,alpha"-tetrachloro-tetradecanedioic acid (Cl-DICA).	lcfas	95-100	insulin	Homo sapiens	116-123
16611988-1	2006	Fatty acid transport protein 1 (FATP1), a member of the FATP/Slc27 protein family, enhances the cellular uptake of long-chain fatty acids (LCFAs) and is expressed in several insulin-sensitive tissues.	lcfas	139-144	solute carrier family 27 member 1	Homo sapiens	0-30
16611988-1	2006	Fatty acid transport protein 1 (FATP1), a member of the FATP/Slc27 protein family, enhances the cellular uptake of long-chain fatty acids (LCFAs) and is expressed in several insulin-sensitive tissues.	lcfas	139-144	solute carrier family 27 member 1	Homo sapiens	32-37
16611988-1	2006	Fatty acid transport protein 1 (FATP1), a member of the FATP/Slc27 protein family, enhances the cellular uptake of long-chain fatty acids (LCFAs) and is expressed in several insulin-sensitive tissues.	lcfas	139-144	solute carrier family 27 member 1	Homo sapiens	32-36
16611988-1	2006	Fatty acid transport protein 1 (FATP1), a member of the FATP/Slc27 protein family, enhances the cellular uptake of long-chain fatty acids (LCFAs) and is expressed in several insulin-sensitive tissues.	lcfas	139-144	insulin	Homo sapiens	174-181
12464674-3	2002	We hypothesized that the transfer of long-chain fatty acids (LCFAs) into the mitochondria via carnitine palmitoyltransferase-1 (CPT-1) is inhibited by increased malonyl coenzyme A (malonyl-CoA) (a known potent inhibitor of CPT-1) in human muscle during hyperglycemia with hyperinsulinemia.	lcfas	61-66	carnitine palmitoyltransferase 1A	Homo sapiens	128-133
12464674-3	2002	We hypothesized that the transfer of long-chain fatty acids (LCFAs) into the mitochondria via carnitine palmitoyltransferase-1 (CPT-1) is inhibited by increased malonyl coenzyme A (malonyl-CoA) (a known potent inhibitor of CPT-1) in human muscle during hyperglycemia with hyperinsulinemia.	lcfas	61-66	carnitine palmitoyltransferase 1A	Homo sapiens	223-228
11284737-1	2001	Liver fatty-acid-binding protein (L-FABP) is a cytoplasmic polypeptide that binds with strong affinity especially to long-chain fatty acids (LCFAs).	lcfas	141-146	fatty acid binding protein 1, liver	Mus musculus	0-32
11352982-6	2001	Our results showed the link between mutations of the FAT/CD36 gene and a defect in the accumulation of LCFAs in the human heart.	lcfas	103-108	CD36 molecule	Homo sapiens	53-56
11284737-1	2001	Liver fatty-acid-binding protein (L-FABP) is a cytoplasmic polypeptide that binds with strong affinity especially to long-chain fatty acids (LCFAs).	lcfas	141-146	fatty acid binding protein 1, liver	Mus musculus	34-40
9604863-14	1998	Long-chain fatty acids (LCFAs), but not medium-chain fatty acids, induced the accumulation of Glc-6-Pase mRNA and the stabilization of the transcript.	lcfas	24-29	glucose-6-phosphatase catalytic subunit 1	Rattus norvegicus	94-104
11171094-4	2001	We found that free LCFAs rather than acyl-CoA esters are the signal metabolites responsible for the stimulation of L-CPT I gene expression.	lcfas	19-24	carnitine palmitoyltransferase 1a, liver	Mus musculus	115-122
10455061-1	1999	Heart-type fatty acid binding protein (H-FABP), abundantly expressed in cardiac myocytes, has been postulated to facilitate the cardiac uptake of long-chain fatty acids (LCFAs) and to promote their intracellular trafficking to sites of metabolic conversion.	lcfas	170-175	fatty acid binding protein 3, muscle and heart	Mus musculus	0-37
10455061-1	1999	Heart-type fatty acid binding protein (H-FABP), abundantly expressed in cardiac myocytes, has been postulated to facilitate the cardiac uptake of long-chain fatty acids (LCFAs) and to promote their intracellular trafficking to sites of metabolic conversion.	lcfas	170-175	fatty acid binding protein 3, muscle and heart	Mus musculus	39-45
10471110-1	1999	The murine fatty acid transport protein (FATP) facilitates uptake of long chain fatty acids (LCFAs) when expressed in mammalian cells.	lcfas	93-98	solute carrier family 27 member 1	Homo sapiens	11-39
10471110-1	1999	The murine fatty acid transport protein (FATP) facilitates uptake of long chain fatty acids (LCFAs) when expressed in mammalian cells.	lcfas	93-98	solute carrier family 27 (fatty acid transporter), member 1	Mus musculus	41-45
9786857-1	1998	The murine fatty acid transport protein (FATP) was identified on the basis of its ability to facilitate uptake of long chain fatty acids (LCFAs) when expressed in mammalian cells.	lcfas	138-143	solute carrier family 27 (fatty acid transporter), member 1	Mus musculus	41-45
34915120-2	2022	We observed that epidermal fatty acid-binding protein (E-FABP/FABP5) with a high affinity for both LCFAs and RA is exclusively expressed in the septoclasts located at the chondro-osseous junction (COJ) of the GP.	lcfas	99-104	fatty acid binding protein 5	Homo sapiens	17-53
34626764-4	2022	This study of the archaea and syntrophic bacteria actively valorising LCFAs at short HRTs and 20 C will help uncover the microbiology underpinning anaerobic bioconversions of fats, oil and grease.	lcfas	70-75	chromosome 10 open reading frame 90	Homo sapiens	175-179
34915120-2	2022	We observed that epidermal fatty acid-binding protein (E-FABP/FABP5) with a high affinity for both LCFAs and RA is exclusively expressed in the septoclasts located at the chondro-osseous junction (COJ) of the GP.	lcfas	99-104	fatty acid binding protein 5	Homo sapiens	55-61
34915120-2	2022	We observed that epidermal fatty acid-binding protein (E-FABP/FABP5) with a high affinity for both LCFAs and RA is exclusively expressed in the septoclasts located at the chondro-osseous junction (COJ) of the GP.	lcfas	99-104	fatty acid binding protein 5	Homo sapiens	62-67
34915120-3	2022	HIGHLIGHTS: E-FABP expressed in septoclasts is involved in both LCFA metabolism and RA signaling as an intracellular transporter of both LCFAs and RA.	lcfas	137-142	fatty acid binding protein 5	Homo sapiens	12-18
34208471-1	2021	TBC1D4 (AS160) and TBC1D1 are Rab GTPase-activating proteins that play a key role in the regulation of glucose and possibly the transport of long chain fatty acids (LCFAs) into muscle and fat cells.	lcfas	165-170	TBC1 domain family member 4	Homo sapiens	0-6
34109887-7	2021	CONCLUSIONS: This carrier strategy for small molecule drugs is based on naturally evolved interactions between long-chain fatty acids (LCFAs) and Human Serum Albumin (HSA), demonstrated here for PTX.	lcfas	135-140	albumin	Mus musculus	152-165
34480991-4	2021	SCFAs and LCFAs activate signaling cascades that control immune functions through interaction with cell surface free fatty acid receptors (FFARs), i.e. FFAR1, FFAR2, FFAR3, and FFAR4.	lcfas	10-15	free fatty acid receptor 1	Homo sapiens	152-157
34480991-4	2021	SCFAs and LCFAs activate signaling cascades that control immune functions through interaction with cell surface free fatty acid receptors (FFARs), i.e. FFAR1, FFAR2, FFAR3, and FFAR4.	lcfas	10-15	free fatty acid receptor 2	Homo sapiens	159-164
34480991-4	2021	SCFAs and LCFAs activate signaling cascades that control immune functions through interaction with cell surface free fatty acid receptors (FFARs), i.e. FFAR1, FFAR2, FFAR3, and FFAR4.	lcfas	10-15	free fatty acid receptor 3	Homo sapiens	166-171
34480991-4	2021	SCFAs and LCFAs activate signaling cascades that control immune functions through interaction with cell surface free fatty acid receptors (FFARs), i.e. FFAR1, FFAR2, FFAR3, and FFAR4.	lcfas	10-15	free fatty acid receptor 4	Homo sapiens	177-182
34208471-1	2021	TBC1D4 (AS160) and TBC1D1 are Rab GTPase-activating proteins that play a key role in the regulation of glucose and possibly the transport of long chain fatty acids (LCFAs) into muscle and fat cells.	lcfas	165-170	TBC1 domain family member 4	Homo sapiens	8-13
34208471-1	2021	TBC1D4 (AS160) and TBC1D1 are Rab GTPase-activating proteins that play a key role in the regulation of glucose and possibly the transport of long chain fatty acids (LCFAs) into muscle and fat cells.	lcfas	165-170	TBC1 domain family member 1	Homo sapiens	19-25
35516426-7	2022	The content of eight long-chain fatty acids (LCFAs) was significantly increased in mice with Rb1, which was positively correlated with the increase of Akkermansia and Parasuttereller, and negatively correlated with the decrease of Oscillibacter and Intestinimonas.	lcfas	45-50	RB transcriptional corepressor 1	Mus musculus	93-96
35447541-4	2022	RESULTS: OCA inhibited hFATP5 (IC50 =0.07 muM) more than murine (m) FATP5 (IC50 =1.04 muM) as measured by LCFAs uptake in FATP5 expressing HEK-293.	lcfas	106-111	solute carrier family 27 member 5	Homo sapiens	23-29
35447541-6	2022	Moreover, OCA inhibited LCFAs uptake by livers in hFATP5 mice and FXR-/-/hFATP5 mice, but not in FXR-/- mice, in vivo.	lcfas	24-29	solute carrier family 27 member 5	Homo sapiens	50-56
35447541-6	2022	Moreover, OCA inhibited LCFAs uptake by livers in hFATP5 mice and FXR-/-/hFATP5 mice, but not in FXR-/- mice, in vivo.	lcfas	24-29	solute carrier family 27 member 5	Homo sapiens	73-79
35447541-8	2022	CONCLUSIONS: OCA ameliorated high-fat diet-induced NAFLD independent of FXR by inhibiting hepatic hFATP5-mediated LCFAs uptake.	lcfas	114-119	solute carrier family 27 member 5	Homo sapiens	98-104
35472681-6	2022	These two LCFAs promoted insulin secretion by inhibiting somatostatin secretion, and showed bias activation of GPR120 in a model system.	lcfas	10-15	somatostatin	Mus musculus	57-69
35472681-6	2022	These two LCFAs promoted insulin secretion by inhibiting somatostatin secretion, and showed bias activation of GPR120 in a model system.	lcfas	10-15	free fatty acid receptor 4	Mus musculus	111-117
35456406-1	2022	The fatty acid-binding protein (FABP) family gene encode a group of proteins that affect long-chain fatty acid (LCFAs) trafficking and play a crucial function in the regulation of milk fat synthesis.	lcfas	112-117	glutamic-oxaloacetic transaminase 2	Homo sapiens	4-30
35456406-1	2022	The fatty acid-binding protein (FABP) family gene encode a group of proteins that affect long-chain fatty acid (LCFAs) trafficking and play a crucial function in the regulation of milk fat synthesis.	lcfas	112-117	glutamic-oxaloacetic transaminase 2	Homo sapiens	32-36
33310598-3	2021	Results demonstrate that the ALK-2-CSTRs effectively promoted methane yield from the co-substrates via promoting hydrolysis, long chain fatty acids (LCFAs) degradation and protecting methanogens from exposure to high concentration of LCFAs directly.	lcfas	149-154	activin A receptor type 1	Homo sapiens	29-34
33923318-3	2021	The ubiquitously distributed FFAR4 can be activated by saturated and unsaturated medium- and long-chain fatty acids (MCFAs and LCFAs), as well as by several synthetic agonists (e.g., TUG-891).	lcfas	127-132	free fatty acid receptor 4	Homo sapiens	29-34
33310598-3	2021	Results demonstrate that the ALK-2-CSTRs effectively promoted methane yield from the co-substrates via promoting hydrolysis, long chain fatty acids (LCFAs) degradation and protecting methanogens from exposure to high concentration of LCFAs directly.	lcfas	234-239	activin A receptor type 1	Homo sapiens	29-34
32491160-5	2020	Here, we found that intrapancreatic CD8+ T cells progressively accumulate specific long-chain fatty acids (LCFAs), which, rather than provide a fuel source, impair their mitochondrial function and trigger major transcriptional reprogramming of pathways involved in lipid metabolism, with the subsequent reduction of fatty acid catabolism.	lcfas	107-112	CD8a molecule	Homo sapiens	36-39
33002557-2	2020	We aimed to determine if physiological levels of LCFAs alter the electrical excitability of pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the arcuate nucleus of the hypothalamus.	lcfas	49-54	pro-opiomelanocortin-alpha	Mus musculus	92-112
33002557-2	2020	We aimed to determine if physiological levels of LCFAs alter the electrical excitability of pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the arcuate nucleus of the hypothalamus.	lcfas	49-54	pro-opiomelanocortin-alpha	Mus musculus	114-118
33002557-2	2020	We aimed to determine if physiological levels of LCFAs alter the electrical excitability of pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the arcuate nucleus of the hypothalamus.	lcfas	49-54	neuropeptide Y	Mus musculus	124-138
33002557-2	2020	We aimed to determine if physiological levels of LCFAs alter the electrical excitability of pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the arcuate nucleus of the hypothalamus.	lcfas	49-54	neuropeptide Y	Mus musculus	140-143
33002557-5	2020	Bath application of LCFAs were found to predominantly inhibit POMC neurons and predominantly excite NPY neurons.	lcfas	20-25	pro-opiomelanocortin-alpha	Mus musculus	62-66
33002557-5	2020	Bath application of LCFAs were found to predominantly inhibit POMC neurons and predominantly excite NPY neurons.	lcfas	20-25	neuropeptide Y	Mus musculus	100-103
32868338-6	2020	Collectively, our data demonstrate that RabGAP-mediated control of skeletal muscle lipid metabolism converges with glucose metabolism at the level of downstream RabGTPases and involves regulated transport of LCFAs via SLC27A4/FATP4.	lcfas	208-213	solute carrier family 27 (fatty acid transporter), member 4	Mus musculus	218-225
32868338-6	2020	Collectively, our data demonstrate that RabGAP-mediated control of skeletal muscle lipid metabolism converges with glucose metabolism at the level of downstream RabGTPases and involves regulated transport of LCFAs via SLC27A4/FATP4.	lcfas	208-213	solute carrier family 27 (fatty acid transporter), member 4	Mus musculus	226-231
33027714-3	2020	Two main functions of FATP2 are to activate long-chain fatty acids (LCFAs) as a very long-chain acyl-coenzyme A (CoA) synthetase (ACSVL) and to transport LCFAs as a fatty acid transporter.	lcfas	68-73	solute carrier family 27 member 2	Homo sapiens	22-27
33027714-3	2020	Two main functions of FATP2 are to activate long-chain fatty acids (LCFAs) as a very long-chain acyl-coenzyme A (CoA) synthetase (ACSVL) and to transport LCFAs as a fatty acid transporter.	lcfas	154-159	solute carrier family 27 member 2	Homo sapiens	22-27
32799609-1	2020	INTRODUCTION: G protein-coupled receptor 120 (GPR120) is a Galphaq coupled GPCR specifically activated by long-chain fatty acids (LCFAs).	lcfas	130-135	free fatty acid receptor 4	Homo sapiens	14-44
32799609-1	2020	INTRODUCTION: G protein-coupled receptor 120 (GPR120) is a Galphaq coupled GPCR specifically activated by long-chain fatty acids (LCFAs).	lcfas	130-135	free fatty acid receptor 4	Homo sapiens	46-52
32799609-1	2020	INTRODUCTION: G protein-coupled receptor 120 (GPR120) is a Galphaq coupled GPCR specifically activated by long-chain fatty acids (LCFAs).	lcfas	130-135	G protein subunit alpha q	Homo sapiens	59-66
32799609-4	2020	Upon stimulation by LCFAs, GPR120 can directly or indirectly modulate hormone secretion from the gastrointestinal tract and pancreas, and regulate lipid and/or glucose metabolism in adipose, liver, and muscle tissues.	lcfas	20-25	free fatty acid receptor 4	Homo sapiens	27-33
32491160-6	2020	In particular, intrapancreatic CD8+ T cells specifically exhibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, which exacerbates accumulation of LCFAs and very-long-chain fatty acids (VLCFAs) that mediate lipotoxicity.	lcfas	177-182	CD8a molecule	Homo sapiens	31-34
32756427-6	2020	Moreover, considering the ability of the long-chain fatty acids (LCFAs) to displace ATRA from FABP5, the actions of the saturated palmitic acid (PA), unsaturated omega-6 linoleic acid (LA) and omega-3 docosahexaenoic acid (DHA) were evaluated to counteract ATRA-related proliferation.	lcfas	65-70	fatty acid binding protein 5	Homo sapiens	94-99
32491160-6	2020	In particular, intrapancreatic CD8+ T cells specifically exhibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, which exacerbates accumulation of LCFAs and very-long-chain fatty acids (VLCFAs) that mediate lipotoxicity.	lcfas	177-182	acyl-Coenzyme A dehydrogenase, very long chain	Mus musculus	88-126
32491160-6	2020	In particular, intrapancreatic CD8+ T cells specifically exhibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, which exacerbates accumulation of LCFAs and very-long-chain fatty acids (VLCFAs) that mediate lipotoxicity.	lcfas	177-182	acyl-Coenzyme A dehydrogenase, very long chain	Mus musculus	128-133
29805599-2	2018	The expression of G-protein coupled receptor 40 (GPR40), a membrane-bound receptor for long-chain fatty acids (LCFAs), was examined in 36 cases of subserosal-invading CRC and compared with clinicopathological parameters as well as triglyceride (TG) and low-density lipoprotein (LDL) levels in the blood.	lcfas	111-116	free fatty acid receptor 1	Homo sapiens	18-47
32541879-5	2020	Free LCFAs induce a Toll-like receptor 4 (TLR4)-NFkappaB-dependent pro-inflammatory signalling cascade in neighbouring vascular pericytes that is rescued by TLR4 inhibition.	lcfas	5-10	toll like receptor 4	Homo sapiens	20-40
32541879-5	2020	Free LCFAs induce a Toll-like receptor 4 (TLR4)-NFkappaB-dependent pro-inflammatory signalling cascade in neighbouring vascular pericytes that is rescued by TLR4 inhibition.	lcfas	5-10	toll like receptor 4	Homo sapiens	42-46
32541879-5	2020	Free LCFAs induce a Toll-like receptor 4 (TLR4)-NFkappaB-dependent pro-inflammatory signalling cascade in neighbouring vascular pericytes that is rescued by TLR4 inhibition.	lcfas	5-10	toll like receptor 4	Homo sapiens	157-161
30989113-4	2019	A RalGAPalpha1Thr735Ala mutation impaired insulin-stimulated muscle assimilation of glucose and LCFAs and caused metabolic syndrome in mice.	lcfas	96-101	Ral GTPase activating protein, alpha subunit 1	Mus musculus	2-14
29805599-2	2018	The expression of G-protein coupled receptor 40 (GPR40), a membrane-bound receptor for long-chain fatty acids (LCFAs), was examined in 36 cases of subserosal-invading CRC and compared with clinicopathological parameters as well as triglyceride (TG) and low-density lipoprotein (LDL) levels in the blood.	lcfas	111-116	free fatty acid receptor 1	Homo sapiens	49-54
27424398-4	2016	PPAR-gamma can induces the pathways to store LCFAs as triglycerides in adipocytes.	lcfas	45-50	peroxisome proliferator activated receptor gamma	Homo sapiens	0-10
26488817-2	2015	We report that long-chain fatty acids (LCFAs) enhanced differentiation and proliferation of T helper 1 (Th1) and/or Th17 cells and impaired their intestinal sequestration via p38-MAPK pathway.	lcfas	39-44	mitogen-activated protein kinase 14	Homo sapiens	175-178
27117849-2	2016	Medium-chain fatty acids (MCFAs) have anti-obesogenic effects in rodents and humans, while long-chain fatty acids (LCFAs) cause increases in body weight and insulin resistance.	lcfas	115-120	insulin	Homo sapiens	157-164
25790461-1	2015	Long chain fatty acids (LCFAs), which are ligands for the G-protein coupled receptor FFAR1 (GPR40), are increased in cow plasma after parturition, a period in which they are highly susceptible to infectious diseases.	lcfas	24-29	free fatty acid receptor 1	Bos taurus	85-90
25790461-6	2015	Expression of the bovine FFAR1 receptor in Chinese hamster ovary (CHO)-K1 cells increased the levels of intracellular calcium induced by the LCFAs, oleic acid (OA) and linoleic acid (LA); no increase in calcium mobilization was observed in the presence of the short chain fatty acid propionic acid.	lcfas	141-146	free fatty acid receptor 1	Bos taurus	25-30
25255125-1	2014	The inhibition of the mammalian de novo synthesis of long-chain saturated fatty acids (LCFAs) by blocking the fatty acid synthase (FASN) enzyme activity in tumor cells that overexpress FASN can promote apoptosis, without apparent cytotoxic to non-tumor cells.	lcfas	87-92	fatty acid synthase	Homo sapiens	110-129
25255125-1	2014	The inhibition of the mammalian de novo synthesis of long-chain saturated fatty acids (LCFAs) by blocking the fatty acid synthase (FASN) enzyme activity in tumor cells that overexpress FASN can promote apoptosis, without apparent cytotoxic to non-tumor cells.	lcfas	87-92	fatty acid synthase	Homo sapiens	131-135
25255125-1	2014	The inhibition of the mammalian de novo synthesis of long-chain saturated fatty acids (LCFAs) by blocking the fatty acid synthase (FASN) enzyme activity in tumor cells that overexpress FASN can promote apoptosis, without apparent cytotoxic to non-tumor cells.	lcfas	87-92	fatty acid synthase	Homo sapiens	185-189
23991914-4	2014	RESULTS: Acsl1 overexpression prevented oxidative stress (nitrotyrosine; hydroxyoctadecadienoic acids [HODEs]) and attenuated cellular injury (TUNEL) in Schwann cells following 12 h exposure to LCFAs (palmitate, linoleate, and oleate, 100 muM).	lcfas	194-199	acyl-CoA synthetase long-chain family member 1	Mus musculus	9-14
23825924-1	2013	Polyunsaturated (PUFA) long-chain fatty acids (LCFAs) are more potent in eliciting molecular and tissue functional changes in monogastrics than saturated LCFA.	lcfas	47-52	PUFA	Bos taurus	17-21
23063128-2	2012	Upon activation by long-chain fatty acids (LCFAs), UCP1 increases the conductance of the inner mitochondrial membrane (IMM) to make BAT mitochondria generate heat rather than ATP.	lcfas	43-48	uncoupling protein 1	Homo sapiens	51-55
23373011-1	2013	In our previous works we established that in an autoinflammatory condition, familial Mediterranean fever (FMF), the gut microbial diversity is specifically restructured, which also results in the altered profiles of microbial long chain fatty acids (LCFAs) present in the systemic metabolome.	lcfas	250-255	MEFV innate immuity regulator, pyrin	Homo sapiens	76-104
22859366-1	2012	The liver expresses high levels of two proteins with high affinity for long-chain fatty acids (LCFAs): liver fatty acid binding protein (L-FABP) and sterol carrier protein-2 (SCP-2).	lcfas	95-100	fatty acid binding protein 1, liver	Mus musculus	103-135
22859366-1	2012	The liver expresses high levels of two proteins with high affinity for long-chain fatty acids (LCFAs): liver fatty acid binding protein (L-FABP) and sterol carrier protein-2 (SCP-2).	lcfas	95-100	fatty acid binding protein 1, liver	Mus musculus	137-143
22859366-1	2012	The liver expresses high levels of two proteins with high affinity for long-chain fatty acids (LCFAs): liver fatty acid binding protein (L-FABP) and sterol carrier protein-2 (SCP-2).	lcfas	95-100	sterol carrier protein 2, liver	Mus musculus	149-173
22859366-1	2012	The liver expresses high levels of two proteins with high affinity for long-chain fatty acids (LCFAs): liver fatty acid binding protein (L-FABP) and sterol carrier protein-2 (SCP-2).	lcfas	95-100	sterol carrier protein 2, liver	Mus musculus	175-180
22988513-4	2012	Feeding a diet supplemented with 0.3% trans-10, cis-12-CLA (wt/wt basis) for 6 weeks increased liver mass and concentration of long-chain fatty acids (LCFAs) in liver, while adipose tissue mass decreased markedly.	lcfas	151-156	clasper	Mus musculus	55-58
17478525-1	2007	The transport of long-chain fatty acids (LCFAs) across mitochondrial membranes is regulated by carnitine palmitoyltransferase I (CPTI) activity.	lcfas	41-46	carnitine palmitoyltransferase 1B	Rattus norvegicus	95-127
17478525-1	2007	The transport of long-chain fatty acids (LCFAs) across mitochondrial membranes is regulated by carnitine palmitoyltransferase I (CPTI) activity.	lcfas	41-46	carnitine palmitoyltransferase 1B	Rattus norvegicus	129-133